Drugmakers reacted with alarm, warning lower prices could stifle innovation, while critics argue Big Pharma has long used that excuse to justify massive profits. The ultimatum sets the stage for a fierce showdown, with Trump framing it as a fight to protect American families and end “global freeloading.” The outcome could reshape both drug costs and the future of U.S. healthcare.